VIRMA is up-regulated in colon adenocarcinoma, and its silencing in colonic adenocarcinoma cell lines has been shown to inhibit tumor growth by blocking the HIF-1 signaling pathway. Here, VIRMA is linked to colon adenocarcinoma.